Diagnosis of ulcerative colitis and Crohn's disease using transabdominal ultrasonography

被引:1
|
作者
Kamano, Toshiaki [1 ]
Nakagawa, Yoshihito [1 ]
Nagasaka, Mitsuo [1 ]
Funasaka, Kohei [1 ]
Miyahara, Ryoji [1 ]
Hashimoto, Senju [1 ]
Shibata, Tomoyuki [1 ]
Hirooka, Yoshiki [1 ]
机构
[1] Fujita Hlth Univ, Dept Gastroenterol & Hepatol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi, Japan
关键词
Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Transabdominal ultrasonography; IMAGES;
D O I
10.1007/s10396-021-01181-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The following are some common features of ulcerative colitis (UC) and Crohn's disease (CD) on transabdominal ultrasonography (TUS). UC, which consists primarily of mucosal inflammation, is seen on TUS as wall thickening with preserved layer structure continuing from the rectum in the active phase of UC. Inflammation confined to the mucosa is seen as thickening of the mucosal/submucosal layers. When the inflammation becomes severe, the echogenicity of the submucosal layer decreases and the layer structure becomes indistinct. CD, which consists primarily of discontinuous transmural inflammation, shows more pronounced hypoechoic wall thickening than UC at the transmural inflammation. On TUS, the layer structure becomes indistinct and gradually disappears due to the depth of the myriad inflammation during the active phase of CD. It is important to evaluate the changes in wall thickening and layer structure when diagnosing UC and CD with TUS. In addition, diagnostic techniques such as color Doppler and contrast-enhanced ultrasonography, which can be used to assess blood flow, and elastography, which can be used to evaluate stiffness, are also used. Thus, TUS is a noninvasive and convenient modality that shows promise as a useful examination for diagnosis of UC and CD.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 50 条
  • [21] Management of ulcerative colitis and Crohn's disease
    Baert, F
    Vermeire, S
    Noman, M
    Van Assche, G
    Haens, GD
    Rutgeerts, P
    ACTA CLINICA BELGICA, 2004, 59 (05) : 304 - 314
  • [22] Tricellulin in Crohn's disease and ulcerative colitis
    Krug, Susanne M.
    Bojarski, Christian
    Fromm, Anja
    Schulzke, Joerg Dieter
    Fromm, Michael
    FASEB JOURNAL, 2010, 24
  • [23] Managing Crohn's disease and ulcerative colitis
    Evans, S
    Ciclitira, PJ
    PRACTITIONER, 1999, 243 (1597) : 307 - +
  • [24] Therapies for Crohn's disease and ulcerative colitis
    Aylett, P
    IDRUGS, 2006, 9 (07) : 452 - 454
  • [25] Pathology of ulcerative colitis and Crohn's disease
    Gebbers, JO
    AUTOIMMUNE DISEASES IN PEDIATRIC GASTROENTEROLOGY, 2002, 127 : 99 - 121
  • [26] Abatacept for Crohn's Disease and Ulcerative Colitis
    Sandborn, William J.
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Rutgeerts, Paul
    Targan, Stephan R.
    Panaccione, Remo
    Bressler, Brian
    Geboes, Karl
    Schreiber, Stefan
    Aranda, Richard
    Gujrathi, Sheila
    Luo, Allison
    Peng, Yun
    Salter-Cid, Luisa
    Hanauer, Stephen B.
    GASTROENTEROLOGY, 2012, 143 (01) : 62 - U575
  • [27] Autoantibodies in ulcerative colitis and Crohn's disease
    Hoier-Madsen, M.
    Vind, I.
    Locht, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) : S84 - S84
  • [28] Biosimilars in Crohn's Disease and Ulcerative Colitis
    Wolf, Douglas C.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (04) : 994 - 997
  • [29] Healthcare resources utilisation prior to the diagnosis of ulcerative colitis and Crohn's disease
    Rodriguez-Lago, I.
    Agirre, U.
    Intxaurza, N.
    Cantero, D.
    Barreiro-de Acosta, M.
    Cabriada, J. L.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S270 - S270
  • [30] Histological biopsy criteria for diagnosis of Crohn's disease and ulcerative colitis.
    Tanaka, M
    Soma, Y
    Saito, H
    Riddell, RH
    Kudo, H
    GASTROENTEROLOGY, 1997, 112 (04) : A1102 - A1102